Connecting patients to clinical trials and care
For cancer patients, access to the right clinical trial can mean the difference between hopeful options and frustrating dead ends.
Yet patients face a complicated and fragmented landscape. Trials are scattered across institutions. Information is incomplete.
Navigating this space is nearly impossible without expert guidance.
Many patients who could benefit from cutting-edge research never find it. The trials exist. As do the patients. It’s a reliable connection that’s missing.
This is an access gap. And it costs lives.
We connect sarcoma patients directly to clinical trials, research, and care options they could not access on their own.
Sarcoma is a rare cancer affecting approximately 16,000 Americans each year. Its rarity means there are fewer treatment options, less research funding, and greater navigation challenges for patients. When you’re facing a rare cancer, finding the right trial shouldn’t require luck or connections.
Fight Sarcoma builds a bridge between patients and the trials that could change their prognosis.
We created a system that identifies relevant trials, matches patients to opportunities, and guides them through the complexity of the enrollment process.
We created a system that identifies relevant trials, matches patients to opportunities, and guides them through the complexity of the enrollment process.
We don’t care about how many pamphlets are distributed or how much awareness is raised. People reaching trials they couldn't access before is our only objective.
Through Fight Sarcoma, we have connected thousands of sarcoma patients to clinical trials, care options, and support services they could not access alone.
Patients who faced dead ends found pathways. Families who felt lost found guidance. People who had no options discovered trials that offered hope.
This is what closing access gaps looks like.
Fight Sarcoma demonstrates our model.
As we grow, we will expand into additional cancer types where access gaps cost lives.
The methodology works and the infrastructure scales. More patients can be connected to care.
